University of Miami | Schiff Center For Liver Diseases

Research site
1500 NW 12th Avenue, Suite 1101-E, Miami, Florida, United States of America
Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site


2 of 11
Status: Active
Trial type: Interventional
Funder type: Industry

A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 )

This Phase 3 study is conducted to evaluate lanifibranor in adults with NASH and liver fibrosis histological stage F2 or F3

NASH - Nonalcoholic Steatohepatitis
Drug: Placebo
Drug: IVA337

The purpose of this clinical research study is to learn more about the use of the study medicine, volixibat, for the treatment of pruritus (itching)...

Primary Biliary Cholangitis
Drug: Volixibat
Drug: Placebo

Trial conditions

Fatty Liver (5 trials)
Non-alcoholic Fatty Live... (5 trials)
Hepatitis C (3 trials)
Biliary Liver Cirrhosis (2 trials)
Cholangitis (2 trials)
Fibrosis (2 trials)
Hepatitis (2 trials)
Hepatitis A (2 trials)
Carcinoma (1 trial)
Chronic Hepatitis C (1 trial)

And 3 more

Clinical trials

Find clinical trialsTrials by location


© Copyright 2024 Veeva Systems